The following summarizes the report contents by section:
SECTION I: Market Status, Trends and Forecasts
Analysis of recent sales, competitive challenges, new products in the pipeline and forces affecting future growth. Also provides sales forecasts to 2008. Products include:
- Implantable prostate seeds, product mix of Pd-103 and I-125 seeds, manufacturer’s sales and market share, distributor revenues and margins, pricing and competitive factors, new product features and cost trade-offs.
- Endovascular brachytherapy sales by manufacturer, product features and new clinical applications, pricing and competitive pressures, effect of drug eluting stents on future demand.
- Post-surgical brachytherapy sales of newly approved products, new technology in the pipeline, future clinical applications and regulatory issues.
- Growth in demand for irradiated microspheres for liver cancer, product features, clinical experience and new applications.
SECTION II: Analysis of Procedure Volume
- Procedure volume for brachytherapy by product category and clinical application including prostate seed implants, endovascular brachytherapy, post-surgical brachytherapy and irradiated microsphere infusion.
- Comparative procedure volume for therapeutic radiopharmaceuticals. Incidence of disease and relationship to new radiotherapy procedures. Forecast procedure volume by disease category from 2002-2008 with rationale for these projections.
SECTION III: Radioisotope Products and Applications
- Technical principles and functional characteristics of brachytherapy products.
- Options in selecting brachytherapy isotopes for specific applications.
SECTION IV: Current Developments and Emerging Technologies
- Discussion of design principles and functional advantages of new brachytherapy products, with analysis of technological prospects and potential applications.
- Analysis of product characteristics and performance trade-offs in each of the brachytherapy applications.
SECTION V: End-User Analysis
- Analysis of end-user groups and comparative requirements for brachytherapy products.
- Procedure mix and product utilization in hospitals and clinics.
SECTION VI: Company Profiles
- Background information on companies in the field and review of recent performance.
- Discussion of each company's market activities and management strategies.
|
Back to Top
BTSI170.doc
-OR-
BTSI170.pdf
Send
this page to a friend